Human medicines European public assessment report (EPAR): Remicade, infliximab, Date of authorisation: 13/08/1999, Revision: 69, Status: Authorised
We are pleased to announce the European Summer School of Internal Medicine (ESIM) 2026!
Following the great success of the previous ESIM Summer School, we are pleased to announce that ESIM Summer 2026 will take place from 31 May to 6 June 2026 at the Astir Egnatia Hotel and the University Hospital of Alexandroupolis, in the beautiful coastal city of Alexandroupolis, Greece.
This will be the second edition of the ESIM Summer School organised by the Hellenic Society of Internal Medicine, under the leadership of Prof. Panagiotis Skendros.
Worksharing: questions and answers
Type-II variations: questions and answers
Extensions of marketing authorisations: questions and answers
Human medicines European public assessment report (EPAR): Repatha, evolocumab, Date of authorisation: 17/07/2015, Revision: 27, Status: Authorised
Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 28, Status: Authorised
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with tracked changes
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
Good Manufacturing Practice (GMP) / Good Distribution Practice (GDP) Inspectors Working Group